European Society for Medical Oncology Preceptorship on Gastric Cancer 2023 Valencia PDF
Format: 24 pdfs, size: 59.3 MB
Course Audience: oncologist
Overview:
- Start date: 29 Sep 2023
- End date: 30 Sep 2023
- Location: Valencia, Spain
Learning objectives
- To learn about the fundamentals of epidemiology, aetiology, pathogenesis, molecular events and immune biology of gastric and esophago-gastric junction cancer
- To understand the essentials in the diagnosis and multidisciplinary treatment of gastric cancer
- To learn about advances in the treatment and novel targets in gastric cancer
Biologically Targeted Treatment (HER2, Claudin 18.2, FGFR2, and Beyond) (PDF Format)
Clinically Useful Pathology Biomarkers (with some genomics!) (PDF Format)ESMO-Preceptorship-on-Gastric-Cancer-2023-Valencia-Programme (PDF Format)Gastric Cancer as a Global Problem (PDF Format)Genomics and Pathology of Hereditary Cancers (PDF Format)Immunotherapy for Advanced Gastroesophageal Adenocarcinoma (PDF Format)Participants Clinical Case Discussion – A Case of a Patient with Oesophago-gastric Junction (OGJ) Adenocarcinoma in Stage IV- A Therapeutic Continuum (PDF Format)Participants Clinical Case Discussion – A Perioperative Dilemma (PDF Format)Participants Clinical Case Discussion – Addition of Durvalumab to Perioperative and Maintenance Therapy in Localised Advanced Cancer- Report of a Case (PDF Format)Participants Clinical Case Discussion – Case Discussion- Immune Mediated Colitis (PDF Format)Participants Clinical Case Discussion – dMMR Elderly Patient Treated with Nivolumab (PDF Format)Participants Clinical Case Discussion – From stage IV to CR- An HER2 fairytale (PDF Format)Participants Clinical Case Discussion – Management of Oligometastatic Disease in Oesophago-Gastric Adenocarcinoma (PDF Format)Participants Clinical Case Discussion – Multimodal Treatment of Locally Advanced GEJ Cancer (PDF Format)Participants Clinical Case Discussion – Neoadjuvant Immunotherapy for MSI-HdMMR Gastric Cancer (PDF Format)Participants Clinical Case Discussion – Post-FLOT Progression in PDL1 Gastric Cancer (PDF Format)Participants Clinical Case Discussion – Recurrent Bleeding in Frail Patient with Gastric Cancer (PDF Format)Participants Clinical Case Discussion – The Role of Cytoreductive Surgery and HIPEC in Gastric Cancer with MSI-H Phenotype (PDF Format)Particular Aspects in Patients with Squamous Cell Histology (Peri-Operative and Advanced) (PDF Format)Perioperative Treatment for Gastric Cancer- State of the Art and Current Controversies (PDF Format)Radiation Therapy for Gastric Cancer, and Oesophago-Gastric Junction Cancer (PDF Format)Sequential Chemotherapy (Doublet, Triplet, Elderly Patients, Sequences, Anti-Angiogenic Therapy, Oral Cchemotherapy) (PDF Format)Surgery for Gastric and EG Junction Cancer, Primary, Palliative – Where and When (PDF Format)Welcome from ESMO and Introduction (PDF Format)